Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant

Paula de Michelena, Ignacio Torres, Ángela Ramos-García, Victoria Gosalbes, Nidia Ruiz, Ana Sanmartín, Pilar Botija, Sandrine Poujois, Dixie Huntley, Eliseo Albert, David Navarro
doi: https://doi.org/10.1101/2022.02.02.22270295

Article usage

Article usage: February 2022 to November 2024

AbstractFullPdf
Feb 2022107331262
Mar 20222042662
Apr 202295332
May 202275320
Jun 202299015
Jul 202213205
Aug 20224094
Sep 202272013
Oct 20223508
Nov 202244111
Dec 20223109
Jan 20232327
Feb 20232836
Mar 20231813
Apr 20233814
May 20231343
Jun 20231151
Jul 20232527
Aug 202318105
Sep 20231555
Oct 20231124
Nov 20231754
Dec 20231345
Jan 20241545
Feb 20241727
Mar 2024853
Apr 20241086
May 2024611
Jun 20242376
Jul 20245011
Aug 202421112
Sep 20241988
Oct 2024955
Nov 2024713
Back to top
Posted February 02, 2022.
Download PDF
Data/Code
Email
Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
Paula de Michelena, Ignacio Torres, Ángela Ramos-García, Victoria Gosalbes, Nidia Ruiz, Ana Sanmartín, Pilar Botija, Sandrine Poujois, Dixie Huntley, Eliseo Albert, David Navarro
medRxiv 2022.02.02.22270295; doi: https://doi.org/10.1101/2022.02.02.22270295
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area